Monitoring the cancer genome in plasma using circulating tumour DNA
5 Jul 2016
Monitoring the cancer genome in plasma using circulating tumour DNA
Models and critical preclinical data shaping personal therapy
Cancer organoids
Serum miRNAs as diagnostic tools in GI malignancies
Combination trial designs: efficient, effective and tolerable regimens
Patient perspectives in precision medicine: 'No innovation about us without us'
Liquid biopsies to track clonal evolution and resistance in mCRC
Preclinical strategies for precision medicine in colorectal cancer
WIN 2016 highlights: Emerging technologies
Critique of the SHIVA trial
Personalising breast cancer therapy
Affordable next generation sequencing to support decision making